Since shrimp are bottom feeders, everything that eats them, including humans, will end up intaking these RNA chemicals through the muscle tissue, or meat, of these animals. Once ViAqua, as the Israeli venture capital operation calls itself, gets its RNA-based vaccine product into ocean life as planned, Americans and the world will have one less safe meat product to consume.
According to reports, ViAqua's RNA-based vaccine, which is still in development, uses ribonucleic acid interference (RNAi) to manipulate the genetic profile of shrimp, essentially turning the sea creatures into living genetically modified organisms (GMOs).
"RNAi is a biological process where RNA molecules are used to inhibit gene expression or translation by neutralizing targeted mRNA molecules," reports Epoch Health about the Frankenfood technology.
(Related: Scientists at MIT have confirmed that RNA vaccines are absorbed through the stomach lining and intestines – this would seem to include mRNA vaccines in animal meat.)
Instead of using needles to inject each and every shrimp – because that would be silly, eh? – ViAqua's mad scientists are planning to "inject" the RNAi poison into the food that shrimp consume. A specially coated feed supplement designed to resist white spot syndrome virus (WSSV) – or so we are told – will be added to farmed shrimp feed in an attempt to stymie the loss of $3 billion worth of shrimp every year.
We are told that 15 percent of the world's shrimp production is lost every year to WSSV, which is what ViAqua says it wants to stop by mass-vaccinating shrimp with RNAi drugs.
"ViAqua suggests RNA molecules can inhibit the expression of genes that cause disease with every meal containing its coated product," reports explain.
Also known as a "nanovaccine," ViAqua's RNAi drug was supposedly found in a 2022 "proof-of-concept" study to be 80 percent effective against WSSV in vivo (in living organisms). At the very same time, the study did not assess the potential long-term impact of creating GMO shrimp – not to mention the long-term impact of what will become of humans who eat them as "food."
"Oral delivery is the holy grail of aquaculture health development due to both the impossibility of vaccinating individual shrimp and its ability to substantially bring down the operational costs of disease management while improving outcomes," proudly announced Shai Ufaz, the CEO of ViAqua.
"We are excited to bring this technology to market to address the need for affordable disease solutions in aquaculture."
The first GMO shrimp from ViAqua is expected to be produced starting in India in the year 2024.
Another company called Genvax Technologies also recently launched a startup to develop mRNA "vaccines" for other animals, having secured $6.5 million in funding to develop a self-amplifying mRNA (saRNA) platform to rapidly develop herd- or flock-specific vaccine injections for all sorts of animal species.
Genvax's approach involves inserting a specific "transgene" or "gene of interest" based on the matched variant strain of a virus or disease. The saRNA portion of the technology then generates an antibody response, we are told, without requiring the entire pathogen to be matched to a given circulating disease strain.
The latest news about the mRNA assault on humanity through both health care and the food supply can be found at ChemicalViolence.com.
Sources for this article include: